Literature DB >> 19680116

Basic science and clinical aspects of achilles tendinopathy.

Mohammad Saqib Zafar1, Ansar Mahmood, Nicola Maffulli.   

Abstract

Achilles tendinopathy is one of the common disorders seen in athletes. It is a degenerative rather than an inflammatory, condition. There is a lifetime risk of 52% in former elite male distance runners. This condition is difficult to manage and up to 29% of Achilles tendinopathy patients may require surgery. It often results in chronic pain and discomfort along with failure to regain full function. It can be complicated by partial tears or complete rupture causing long-term burden on healthcare system and making treatment quite difficult.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19680116     DOI: 10.1097/JSA.0b013e3181b37eb7

Source DB:  PubMed          Journal:  Sports Med Arthrosc Rev        ISSN: 1062-8592            Impact factor:   1.985


  19 in total

1.  Matrix metalloproteases and their inhibitors are altered in torn rotator cuff tendons, but also in the macroscopically and histologically intact portion of those tendons.

Authors:  Alessandro Castagna; Eugenio Cesari; Raffaele Garofalo; Antonio Gigante; Marco Conti; Nikolaos Markopoulos; Nicola Maffulli
Journal:  Muscles Ligaments Tendons J       Date:  2013-08-11

2.  Neovascularization in Achilles tendinopathy: have we been chasing a red herring?

Authors:  Johannes L Tol; Filippo Spiezia; Nicola Maffulli
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-08-14       Impact factor: 4.342

3.  Manual therapy and eccentric exercise in the management of Achilles tendinopathy.

Authors:  Dhinu J Jayaseelan; Michael Kecman; Daniel Alcorn; Josiah D Sault
Journal:  J Man Manip Ther       Date:  2016-05-30

Review 4.  [Diseases and overuse injuries of the lower extremities in long distance runners].

Authors:  M Tschopp; F Brunner
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

5.  Metalloproteases and their inhibitors are altered in both torn and intact rotator cuff tendons.

Authors:  A Castagna; E Cesari; A Gigante; M Conti; R Garofalo
Journal:  Musculoskelet Surg       Date:  2013-04-21

6.  Single injection of platelet-rich plasma in a rat Achilles tendon tear model.

Authors:  Antonina Parafioriti; Elisabetta Armiraglio; Silvia Del Bianco; Elisabetta Tibalt; Francesco Oliva; Anna C Berardi
Journal:  Muscles Ligaments Tendons J       Date:  2011-12-29

7.  Intratendinous tears of the Achilles tendon - a new pathology? Analysis of a large 4-year cohort.

Authors:  Otto Chan; Sarah Morton; Mel Pritchard; Tina Parkes; Peter Malliaras; Tom Crisp; Nat Padhiar; Nicola Maffulli; John King; Dylan Morrissey
Journal:  Muscles Ligaments Tendons J       Date:  2017-05-10

8.  Biomechanical evaluation in runners with Achilles tendinopathy.

Authors:  Nathalie Ferrari Bechara Andere; Alexandre Leme Godoy; Luis Mochizuki; Marcelo Bordalo Rodrigues; Túlio Diniz Fernandes; José Maria Soares-Júnior; Angélica Castilho Alonso; Natália Mariana Silva Luna; Guilherme Carlos Brech; Júlia Maria D'Andréa Greve
Journal:  Clinics (Sao Paulo)       Date:  2021-06-11       Impact factor: 2.365

9.  Impact of autologous blood injections in treatment of mid-portion Achilles tendinopathy: double blind randomised controlled trial.

Authors:  Kevin J Bell; Mark L Fulcher; David S Rowlands; Ngaire Kerse
Journal:  BMJ       Date:  2013-04-18

10.  Extracorporeal Shock Wave Treatment (ESWT) improves in vitro functional activities of ruptured human tendon-derived tenocytes.

Authors:  Laura Leone; Mario Vetrano; Danilo Ranieri; Salvatore Raffa; Maria Chiara Vulpiani; Andrea Ferretti; Maria Rosaria Torrisi; Vincenzo Visco
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.